Vault-13

SPHERA FUNDS MANAGEMENT LTD.

TEL AVIV, L3 · CIK 1496201 · 13F filing filed 2024-08-14

Exempt reporting adviser since 2021 · other (specify)

As an employer

$613.6m reported value -0.6% vs Q1 2024
110positions
28.7%in top 10
30 new 29 added 31 reduced 13 sold out vs Q1 2024

Options: 6 call positions ($80.3m notional), 2 put positions ($39.4m notional) – listed below, not included above.

This report includes the holdings of 2 other managers that share the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 BRIDGEBIO PHARMA INC COM BBIO BBIO 910,070 $23.1m3.76% 3.76% AddedShares held: Q3 2023 345.5k, Q4 2023 282.1k, Q1 2024 586.0k, Q2 2024 910.1k +324.1k +324,114 55.3%
2 SANOFI SPONSORED ADR SNY SNY 449,515 $21.8m3.55% 3.55% ReducedShares held: Q3 2023 499.5k, Q4 2023 499.5k, Q1 2024 499.5k, Q2 2024 449.5k -50.0k -50,000 -10.0%
3 CYTOKINETICS INC COM NEW CYTK CYTK 384,924 $20.9m3.40% 3.40% AddedShares held: Q3 2023 233.9k, Q4 2023 223.8k, Q1 2024 281.7k, Q2 2024 384.9k +103.3k +103,253 36.7%
4 AMAZON COM INC COM AMZN AMZN 101,432 $19.6m3.19% 3.19% AddedShares held: Q3 2023 95.3k, Q4 2023 55.7k, Q1 2024 54.4k, Q2 2024 101.4k +47.0k +47,000 86.3%
5 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 822,047 $16.9m2.75% 2.75% AddedShares held: Q3 2023 773.1k, Q4 2023 773.0k, Q1 2024 813.0k, Q2 2024 822.0k +9.1k +9,083 1.1%
6 META PLATFORMS INC CL A META META 33,439 $16.9m2.75% 2.75% AddedShares held: Q3 2023 15.2k, Q4 2023 34.3k, Q1 2024 25.4k, Q2 2024 33.4k +8.0k +8,000 31.4%
7 ASTRAZENECA PLC SPONSORED ADR SPONSORED ADR 190,060 $14.8m2.42% 2.42% UnchangedShares held: Q3 2023 285.1k, Q4 2023 180.1k, Q1 2024 190.1k, Q2 2024 190.1k
8 MICROSOFT CORP COM MSFT MSFT 32,927 $14.7m2.40% 2.40% AddedShares held: Q3 2023 34.4k, Q4 2023 23.8k, Q1 2024 27.5k, Q2 2024 32.9k +5.4k +5,379 19.5%
9 NICE LTD SPONSORED ADR NICE NICE 81,461 $14.0m2.28% 2.28% ReducedShares held: Q3 2023 37.5k, Q4 2023 67.7k, Q1 2024 85.9k, Q2 2024 81.5k -4.4k -4,420 -5.2%
10 SAREPTA THERAPEUTICS INC COM SRPT SRPT 83,659 $13.2m2.15% 2.15% AddedShares held: Q3 2023 50.0k, Q4 2023 12.5k, Q1 2024 55.6k, Q2 2024 83.7k +28.0k +28,045 50.4%
11 APPLE INC COM AAPL AAPL 61,500 $13.0m2.11% 2.11% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 17.5k, Q2 2024 61.5k +44.0k +44,000 251.4%
12 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS SPONSORED ADS 789,416 $12.8m2.09% 2.09% ReducedShares held: Q3 2023 600.0k, Q4 2023 2.5m, Q1 2024 1.9m, Q2 2024 789.4k -1.1m -1,100,284 -58.2%
13 KURA ONCOLOGY INC COM KURA KURA 610,826 $12.6m2.05% 2.05% UnchangedShares held: Q3 2023 703.3k, Q4 2023 703.3k, Q1 2024 610.8k, Q2 2024 610.8k
14 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 293,832 $12.1m1.97% 1.97% AddedShares held: Q3 2023 259.1k, Q4 2023 201.0k, Q1 2024 238.5k, Q2 2024 293.8k +55.3k +55,288 23.2%
15 ELI LILLY & CO COM LLY LLY 13,190 $11.9m1.95% 1.95% ReducedShares held: Q3 2023 14.2k, Q4 2023 14.2k, Q1 2024 14.2k, Q2 2024 13.2k -1.0k -1,000 -7.0%
16 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 283,424 $11.7m1.91% 1.91% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 177.1k, Q2 2024 283.4k +106.3k +106,285 60.0%
17 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 309,265 $11.4m1.87% 1.87% AddedShares held: Q3 2023 180.0k, Q4 2023 315.6k, Q1 2024 277.0k, Q2 2024 309.3k +32.3k +32,269 11.7%
18 NOVO-NORDISK A S ADR NVO NVO 78,080 $11.1m1.82% 1.82% ReducedShares held: Q3 2023 93.1k, Q4 2023 93.1k, Q1 2024 83.1k, Q2 2024 78.1k -5.0k -5,000 -6.0%
19 BIOGEN INC COM BIIB BIIB 47,412 $11.0m1.79% 1.79% ReducedShares held: Q3 2023 25.8k, Q4 2023 46.3k, Q1 2024 70.6k, Q2 2024 47.4k -23.2k -23,234 -32.9%
20 SKYE BIOSCIENCE INC COM NEW COM NEW 1,298,312 $10.4m1.69% 1.69% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 1.3m
21 JASPER THERAPEUTICS INC COM NEW JSPR JSPR 454,227 $10.3m1.68% 1.68% ReducedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 505.2k, Q2 2024 454.2k -51.0k -51,015 -10.1%
22 JOHNSON & JOHNSON COM JNJ JNJ 69,831 $10.2m1.66% 1.66% ReducedShares held: Q3 2023 94.8k, Q4 2023 79.8k, Q1 2024 79.8k, Q2 2024 69.8k -10.0k -10,000 -12.5%
23 ASML HOLDING N V N Y REGISTRY SHS ASML ASML 9,901 $10.1m1.65% 1.65% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 9.9k
24 MERUS N V COM MRUS MRUS 147,633 $8.7m1.42% 1.42% ReducedShares held: Q3 2023 253.3k, Q4 2023 230.3k, Q1 2024 149.3k, Q2 2024 147.6k -1.7k -1,700 -1.1%
25 SALESFORCE INC COM CRM CRM 33,600 $8.6m1.41% 1.41% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 33.6k
26 IMMATICS N.V SHS IMTX IMTX 731,111 $8.5m1.38% 1.38% AddedShares held: Q3 2023 617.2k, Q4 2023 621.1k, Q1 2024 666.1k, Q2 2024 731.1k +65.0k +65,000 9.8%
27 PERSPECTIVE THERAPEUTICS INC COM NEW CATX CATX 786,909 $7.8m1.28% 1.28% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 786.9k
28 PHARVARIS N V COM PHVS PHVS 403,265 $7.6m1.24% 1.24% AddedShares held: Q3 2023 0, Q4 2023 245.0k, Q1 2024 392.9k, Q2 2024 403.3k +10.4k +10,388 2.6%
29 MERCK & CO INC COM MRK MRK 59,600 $7.4m1.20% 1.20% ReducedShares held: Q3 2023 123.6k, Q4 2023 123.6k, Q1 2024 103.6k, Q2 2024 59.6k -44.0k -44,000 -42.5%
30 REZOLUTE INC COM NEW RZLT RZLT 1,707,999 $7.3m1.20% 1.20% AddedShares held: Q3 2023 996.7k, Q4 2023 996.7k, Q1 2024 996.7k, Q2 2024 1.7m +711.3k +711,289 71.4%
31 CYBIN INC COM COM 25,581,395 $6.9m1.13% 1.13% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 25.6m, Q2 2024 25.6m
32 VIGIL NEUROSCIENCE INC COM VIGL VIGL 1,692,166 $6.8m1.10% 1.10% ReducedShares held: Q3 2023 0, Q4 2023 535.1k, Q1 2024 1.7m, Q2 2024 1.7m -38.2k -38,248 -2.2%
33 IONIS PHARMACEUTICALS INC COM IONS IONS 140,238 $6.7m1.09% 1.09% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 140.2k
34 INOZYME PHARMA INC COM COM 1,462,724 $6.5m1.06% 1.06% AddedShares held: Q3 2023 1.2m, Q4 2023 1.6m, Q1 2024 1.4m, Q2 2024 1.5m +89.8k +89,817 6.5%
35 ABBVIE INC COM ABBV ABBV 38,000 $6.5m1.06% 1.06% UnchangedShares held: Q3 2023 46.0k, Q4 2023 46.0k, Q1 2024 38.0k, Q2 2024 38.0k
36 PALO ALTO NETWORKS INC COM PANW PANW 18,000 $6.1m0.99% 0.99% NewShares held: Q3 2023 28.8k, Q4 2023 16.6k, Q1 2024 0, Q2 2024 18.0k
37 SENTINELONE INC CL A S S 283,804 $6.0m0.97% 0.97% ReducedShares held: Q3 2023 0, Q4 2023 213.4k, Q1 2024 550.8k, Q2 2024 283.8k -267.0k -267,014 -48.5%
38 TOWER SEMICONDUCTOR LTD SHS NEW TSEM TSEM 149,600 $5.9m0.96% 0.96% ReducedShares held: Q3 2023 469.6k, Q4 2023 528.3k, Q1 2024 179.6k, Q2 2024 149.6k -30.0k -30,000 -16.7%
39 APPLIED MATLS INC COM AMAT AMAT 24,604 $5.8m0.95% 0.95% ReducedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 32.0k, Q2 2024 24.6k -7.4k -7,396 -23.1%
40 ENPHASE ENERGY INC COM ENPH ENPH 56,792 $5.7m0.92% 0.92% AddedShares held: Q3 2023 0, Q4 2023 34.8k, Q1 2024 47.2k, Q2 2024 56.8k +9.6k +9,609 20.4%
41 NOVARTIS AG SPONSORED ADR NVS NVS 50,000 $5.3m0.87% 0.87% UnchangedShares held: Q3 2023 60.0k, Q4 2023 60.0k, Q1 2024 50.0k, Q2 2024 50.0k
42 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 327,539 $5.3m0.87% 0.87% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 125.0k, Q2 2024 327.5k +202.5k +202,539 162.0%
43 MINERALYS THERAPEUTICS INC COM MLYS MLYS 442,752 $5.2m0.84% 0.84% ReducedShares held: Q3 2023 455.4k, Q4 2023 743.6k, Q1 2024 658.8k, Q2 2024 442.8k -216.1k -216,051 -32.8%
44 4D MOLECULAR THERAPEUTICS IN COM FDMT FDMT 242,526 $5.1m0.83% 0.83% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 162.2k, Q2 2024 242.5k +80.4k +80,365 49.6%
45 MICRON TECHNOLOGY INC COM MU MU 37,000 $4.9m0.79% 0.79% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 37.0k
46 DAY ONE BIOPHARMACEUTICALS I COM COM 347,627 $4.8m0.78% 0.78% ReducedShares held: Q3 2023 530.0k, Q4 2023 513.0k, Q1 2024 492.6k, Q2 2024 347.6k -145.0k -145,000 -29.4%
47 CATALYST PHARMACEUTICALS INC COM CPRX CPRX 288,000 $4.5m0.73% 0.73% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 288.0k, Q2 2024 288.0k
48 ROCKET PHARMACEUTICALS INC COM RCKT RCKT 206,933 $4.5m0.73% 0.73% AddedShares held: Q3 2023 209.0k, Q4 2023 190.8k, Q1 2024 183.7k, Q2 2024 206.9k +23.2k +23,211 12.6%
49 JFROG LTD ORD SHS FROG FROG 117,881 $4.4m0.72% 0.72% ReducedShares held: Q3 2023 0, Q4 2023 109.9k, Q1 2024 224.4k, Q2 2024 117.9k -106.5k -106,500 -47.5%
50 89BIO INC COM ETNB ETNB 526,547 $4.2m0.69% 0.69% AddedShares held: Q3 2023 319.3k, Q4 2023 408.7k, Q1 2024 515.9k, Q2 2024 526.5k +10.7k +10,665 2.1%
51 OUTLOOK THERAPEUTICS INC COM OTLK OTLK 571,428 $4.2m0.69% 0.69% ReducedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 571.4k, Q2 2024 571.4k -1 -1 0.0%
52 WIX COM LTD SHS WIX WIX 25,177 $4.0m0.65% 0.65% ReducedShares held: Q3 2023 0, Q4 2023 57.5k, Q1 2024 52.9k, Q2 2024 25.2k -27.7k -27,700 -52.4%
53 LAM RESEARCH CORP COM COM 3,700 $3.9m0.64% 0.64% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 3.7k
54 SAVARA INC COM SVRA SVRA 962,687 $3.9m0.63% 0.63% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 962.7k
55 GSK PLC SPONSORED ADR GSK GSK 100,000 $3.9m0.63% 0.63% UnchangedShares held: Q3 2023 100.0k, Q4 2023 100.0k, Q1 2024 100.0k, Q2 2024 100.0k
56 QUALCOMM INC COM QCOM QCOM 18,825 $3.7m0.61% 0.61% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 15.0k, Q2 2024 18.8k +3.8k +3,825 25.5%
57 ELEDON PHARMACEUTICALS INC COM ELDN ELDN 1,297,021 $3.4m0.56% 0.56% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 1.3m
58 AKERO THERAPEUTICS INC COM AKRO AKRO 141,620 $3.3m0.54% 0.54% ReducedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 160.4k, Q2 2024 141.6k -18.8k -18,825 -11.7%
59 SHL TELEMEDICINE LTD SPONSORED ADS SHLT SHLT 632,456 $3.2m0.53% 0.53% UnchangedShares held: Q3 2023 632.3k, Q4 2023 632.5k, Q1 2024 632.5k, Q2 2024 632.5k
60 APPLIED THERAPEUTICS INC COM APLT APLT 674,268 $3.1m0.51% 0.51% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 619.0k, Q2 2024 674.3k +55.2k +55,239 8.9%
61 INTELLIA THERAPEUTICS INC COM NTLA NTLA 139,419 $3.1m0.51% 0.51% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 139.4k
62 BROADCOM INC COM AVGO AVGO 19,360 $3.1m0.51% 0.51% AddedShares held: Q3 2023 0, Q4 2023 1.8k, Q1 2024 1.0k, Q2 2024 19.4k +18.4k +18,359 1834.1%
63 ANALOG DEVICES INC COM ADI ADI 13,000 $3.0m0.48% 0.48% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 13.0k
64 PTC THERAPEUTICS INC COM PTCT PTCT 94,318 $2.9m0.47% 0.47% NewShares held: Q3 2023 218.5k, Q4 2023 136.5k, Q1 2024 0, Q2 2024 94.3k
65 VISTAGEN THERAPEUTICS INC COM VTGN VTGN 808,550 $2.8m0.46% 0.46% UnchangedShares held: Q3 2023 100.0k, Q4 2023 808.5k, Q1 2024 808.5k, Q2 2024 808.5k
66 PLIANT THERAPEUTICS INC COM PLRX PLRX 258,554 $2.8m0.45% 0.45% UnchangedShares held: Q3 2023 156.1k, Q4 2023 193.6k, Q1 2024 258.6k, Q2 2024 258.6k
67 ALECTOR INC COM ALEC ALEC 610,000 $2.8m0.45% 0.45% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 560.0k, Q2 2024 610.0k +50.0k +50,000 8.9%
68 ENLIGHT RENEWABLE ENERGY LTD SHS ENLT ENLT 169,280 $2.7m0.45% 0.45% UnchangedShares held: Q3 2023 0, Q4 2023 169.3k, Q1 2024 169.3k, Q2 2024 169.3k
69 PROMIS NEUROSCIENCES INC COM NEW PMN PMN 1,814,213 $2.7m0.44% 0.44% ReducedShares held: Q3 2023 1.8m, Q4 2023 1.8m, Q1 2024 1.8m, Q2 2024 1.8m -19.8k -19,834 -1.1%
70 KLA CORP COM NEW KLAC KLAC 3,300 $2.7m0.44% 0.44% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 3.3k
71 SPRINGWORKS THERAPEUTICS INC COM SWTX SWTX 70,269 $2.6m0.43% 0.43% UnchangedShares held: Q3 2023 319.9k, Q4 2023 170.3k, Q1 2024 70.3k, Q2 2024 70.3k
72 DISC MEDICINE INC COM IRON IRON 58,044 $2.6m0.43% 0.43% AddedShares held: Q3 2023 111.4k, Q4 2023 0, Q1 2024 48.9k, Q2 2024 58.0k +9.2k +9,158 18.7%
73 CARGO THERAPEUTICS INC COM COM 155,506 $2.6m0.42% 0.42% AddedShares held: Q3 2023 0, Q4 2023 75.0k, Q1 2024 75.0k, Q2 2024 155.5k +80.5k +80,506 107.3%
74 PFIZER INC COM PFE PFE 90,000 $2.5m0.41% 0.41% UnchangedShares held: Q3 2023 90.0k, Q4 2023 90.0k, Q1 2024 90.0k, Q2 2024 90.0k
75 NVIDIA CORPORATION COM NVDA NVDA 20,000 $2.5m0.40% 0.40% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 20.0k
76 GLOBAL E ONLINE LTD SHS GLBE GLBE 66,884 $2.4m0.40% 0.40% ReducedShares held: Q3 2023 0, Q4 2023 269.8k, Q1 2024 208.8k, Q2 2024 66.9k -141.9k -141,900 -68.0%
77 VENTYX BIOSCIENCES INC COM VTYX VTYX 1,012,749 $2.3m0.38% 0.38% AddedShares held: Q3 2023 0, Q4 2023 180.0k, Q1 2024 992.7k, Q2 2024 1.0m +20.0k +20,000 2.0%
78 TABOOLA.COM LTD ORD SHS TBLA TBLA 667,384 $2.3m0.37% 0.37% ReducedShares held: Q3 2023 0, Q4 2023 1.7m, Q1 2024 1.2m, Q2 2024 667.4k -523.7k -523,686 -44.0%
79 LARIMAR THERAPEUTICS INC COM LRMR LRMR 312,469 $2.3m0.37% 0.37% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 312.5k
80 L3HARRIS TECHNOLOGIES INC COM LHX LHX 10,000 $2.2m0.37% 0.37% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 10.0k
81 ADC THERAPEUTICS SA SHS ADCT ADCT 685,547 $2.2m0.35% 0.35% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 685.5k
82 NUTRIEN LTD COM NTR NTR 40,730 $2.1m0.34% 0.34% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 35.7k, Q2 2024 40.7k +5.0k +5,000 14.0%
83 PERION NETWORK LTD SHS NEW PERI PERI 234,609 $2.0m0.32% 0.32% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 234.6k
84 KYVERNA THERAPEUTICS INC COM KYTX KYTX 236,029 $1.8m0.29% 0.29% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 236.0k
85 ALUMIS INC COM ALMS ALMS 125,000 $1.7m0.27% 0.27% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 125.0k
86 CLIMB BIO INC COM CLYM CLYM 215,179 $1.5m0.25% 0.25% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 215.2k
87 WEREWOLF THERAPEUTICS INC COM HOWL HOWL 626,810 $1.5m0.25% 0.25% UnchangedShares held: Q3 2023 626.8k, Q4 2023 626.8k, Q1 2024 626.8k, Q2 2024 626.8k
88 ASTRIA THERAPEUTICS INC COM CATB CATB 162,842 $1.5m0.24% 0.24% AddedShares held: Q3 2023 580.6k, Q4 2023 1.2m, Q1 2024 112.8k, Q2 2024 162.8k +50.0k +50,000 44.3%
89 VIR BIOTECHNOLOGY INC COM VIR VIR 162,051 $1.4m0.24% 0.24% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 162.1k
90 MONTE ROSA THERAPEUTICS INC COM GLUE GLUE 375,000 $1.4m0.23% 0.23% NewShares held: Q3 2023 0, Q4 2023 48.5k, Q1 2024 0, Q2 2024 375.0k
91 MARVELL TECHNOLOGY INC COM MRVL MRVL 20,000 $1.4m0.23% 0.23% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 20.0k
92 UPWORK INC COM UPWK UPWK 117,000 $1.3m0.20% 0.20% UnchangedShares held: Q3 2023 0, Q4 2023 252.8k, Q1 2024 117.0k, Q2 2024 117.0k
93 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 48,175 $1.3m0.20% 0.20% NewShares held: Q3 2023 0, Q4 2023 144.9k, Q1 2024 0, Q2 2024 48.2k
94 COMPUGEN LTD ORD CGEN CGEN 739,239 $1.2m0.20% 0.20% ReducedShares held: Q3 2023 1.3m, Q4 2023 769.2k, Q1 2024 769.2k, Q2 2024 739.2k -30.0k -30,000 -3.9%
95 KEZAR LIFE SCIENCES INC COM COM 2,051,676 $1.2m0.20% 0.20% UnchangedShares held: Q3 2023 2.1m, Q4 2023 2.1m, Q1 2024 2.1m, Q2 2024 2.1m
96 INSMED INC COM PAR $.01 INSM INSM 16,589 $1.1m0.18% 0.18% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 16.6k
97 APREA THERAPEUTICS INC COM NEW APRE APRE 270,000 $1.1m0.18% 0.18% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 270.0k, Q2 2024 270.0k
98 TAIWAN SEMICONDUCTOR MFG LTD SPONSORED ADS TSM TSM 5,650 $982.0k0.16% 0.16% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 5.7k
99 ELEVATION ONCOLOGY INC COM COM 330,000 $891.0k0.15% 0.15% ReducedShares held: Q3 2023 900.0k, Q4 2023 900.0k, Q1 2024 430.0k, Q2 2024 330.0k -100.0k -100,000 -23.3%
100 VARONIS SYS INC COM VRNS VRNS 16,000 $767.5k0.13% 0.13% ReducedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 20.0k, Q2 2024 16.0k -4.0k -4,000 -20.0%

Sold out since Q1 2024

SecurityTickerShares held beforeValue then
PERSPECTIVE THERAPEUTICS INC ISR ISR 12,443,621 $14.8m12.4m shares
FUSION PHARMACEUTICALS INC 449,041 $9.6m449.0k shares
NOVA LTD NVMI NVMI 35,106 $6.2m35.1k shares
INCYTE CORP INCY INCY 89,556 $5.1m89.6k shares
SOLAREDGE TECHNOLOGIES INC SEDG SEDG 40,175 $2.9m40.2k shares
ELASTIC N V ESTC ESTC 20,000 $2.0m20.0k shares
ADVANCED MICRO DEVICES INC AMD AMD 11,000 $2.0m11.0k shares
ALPINE IMMUNE SCIENCES INC NVLS NVLS 44,841 $1.8m44.8k shares
FIVE9 INC FIVN FIVN 27,500 $1.7m27.5k shares
CORBUS PHARMACEUTICALS HLDGS CRBP CRBP 35,000 $1.4m35.0k shares
GERON CORP GERN GERN 384,356 $1.3m384.4k shares
SELECTA BIOSCIENCES INC 25,071 $488.9k25.1k shares
ALTO NEUROSCIENCE INC ANRO ANRO 30,500 $468.2k30.5k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
TEVA PHARMACEUTICAL INDS LTD Call Call 3,268,900 $53.1m3.3m shares Added
VANECK ETF TRUST SMH · Put SMHPut 149,800 $39.1m149.8k shares New
INVESCO QQQ TR QQQ · Call QQQCall 22,900 $11.0m22.9k shares New
NICE LTD NICE · Call NICECall 32,100 $5.5m32.1k shares New
BRIDGEBIO PHARMA INC BBIO · Call BBIOCall 204,600 $5.2m204.6k shares Added
PRAXIS PRECISION MEDICINES I PRAX · Call PRAXCall 75,000 $3.1m75.0k shares New
SAREPTA THERAPEUTICS INC SRPT · Call SRPTCall 15,000 $2.4m15.0k shares New
FULCRUM THERAPEUTICS INC FULC · Put FULCPut 59,000 $365.8k59.0k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
PROMIS NEUROSCIENCES INC PMN · 13G · filed 2026-02-05 PMN 7.8% +2.3 pts 13G 2026-02-05
TENAX THERAPEUTICS INC TENX · 13G · filed 2026-10-13 TENX 7.1%≈ $38.8m +1.8 pts 13G 2026-10-13